Qatar Ureteral Stents Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Qatar Ureteral Stents Market, valued at USD 48 million, is growing due to increasing urinary disorders, medical innovations, and geriatric population demands for effective treatments.

Region:Middle East

Author(s):Rebecca

Product Code:KRAC2822

Pages:86

Published On:January 2026

About the Report

Base Year 2024

Qatar Ureteral Stents Market Overview

  • The Qatar Ureteral Stents Market is valued at USD 48 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of urological disorders, advancements in medical technology, and a growing aging population that requires surgical interventions. The demand for ureteral stents is further supported by the rising awareness of minimally invasive procedures among healthcare professionals and patients alike.
  • Doha is the dominant city in the Qatar Ureteral Stents Market due to its advanced healthcare infrastructure and concentration of specialized medical facilities. The presence of leading hospitals and clinics, along with a high rate of medical tourism, contributes to the market's growth. Additionally, Al Rayyan and Umm Salal are emerging as significant contributors, driven by increasing healthcare investments and expanding patient populations.
  • The Medical Devices Law No. 3 of 2015 issued by the Ministry of Public Health mandates the use of biocompatible materials in medical devices including ureteral stents. This regulation covers registration, quality standards, and safety requirements for imported and locally manufactured devices, requiring manufacturers to obtain product licenses and demonstrate compliance through clinical evaluations and material testing before market entry.
Qatar Ureteral Stents Market Size

Qatar Ureteral Stents Market Segmentation

By Type:The market is segmented into various types of ureteral stents, including Double-J Stents, Ureteral Catheters, Coated Stents, Biodegradable Stents, and Others. Among these, Double-J Stents are the most widely used due to their effectiveness in preventing obstruction and their ease of placement. The increasing preference for minimally invasive procedures has also led to a rise in the adoption of Coated and Biodegradable Stents, which offer additional benefits such as reduced risk of infection and improved patient comfort.

Qatar Ureteral Stents Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others. Hospitals dominate this segment due to their comprehensive facilities and specialized staff capable of performing complex procedures. The increasing number of outpatient surgeries has also led to a rise in the use of Ambulatory Surgical Centers, which provide cost-effective and efficient care for patients requiring ureteral stenting.

Qatar Ureteral Stents Market segmentation by End-User.

Qatar Ureteral Stents Market Competitive Landscape

The Qatar Ureteral Stents Market is characterized by a dynamic mix of regional and international players. Leading participants such as Boston Scientific Corporation, Cook Medical, Medtronic, Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, C. R. Bard, Inc., Olympus Corporation, Stryker Corporation, UroGen Pharma Ltd., ConvaTec Group PLC, Merit Medical Systems, Inc., Endo International PLC, Acelity L.P. Inc., Amgen Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Boston Scientific Corporation

1979

Marlborough, Massachusetts, USA

Cook Medical

1963

Bloomington, Indiana, USA

Medtronic

1949

Dublin, Ireland

Teleflex Incorporated

1943

Wayne, Pennsylvania, USA

B. Braun Melsungen AG

1839

Melsungen, Germany

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Qatar Ureteral Stents Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Urinary Tract Disorders:The prevalence of urinary tract disorders in Qatar is rising, with approximately 1,200 new cases reported annually. This increase is attributed to lifestyle changes and a growing population, which reached 2.9 million in future. The World Health Organization indicates that urinary disorders affect around 10% of the global population, suggesting a significant market potential for ureteral stents in Qatar as healthcare providers seek effective treatment options.
  • Advancements in Medical Technology:The Qatar healthcare sector is experiencing rapid technological advancements, with healthcare spending projected to reach USD 12 billion in future. Innovations in ureteral stent design, such as the development of biocompatible materials, are enhancing patient outcomes. The integration of minimally invasive techniques is also gaining traction, leading to increased adoption of advanced stent technologies that improve recovery times and reduce complications, thus driving market growth.
  • Rising Geriatric Population:Qatar's geriatric population is expected to grow significantly, with projections indicating that individuals aged 65 and older will reach 10% of the total population in future. This demographic shift is associated with a higher incidence of urinary tract disorders, necessitating effective management solutions. The increasing demand for ureteral stents among older adults is a critical driver for market expansion, as healthcare systems adapt to meet their unique needs.

Market Challenges

  • High Cost of Ureteral Stents:The cost of ureteral stents in Qatar can range from QAR 1,500 to QAR 3,000 per unit, which poses a significant barrier to widespread adoption. Many patients face financial constraints, limiting their access to necessary treatments. Additionally, healthcare providers may hesitate to invest in expensive stent technologies, impacting overall market growth. This challenge necessitates the development of cost-effective solutions to enhance accessibility.
  • Limited Awareness Among Patients:Awareness of ureteral stents and their benefits remains low among the Qatari population, with only 30% of patients familiar with these devices. This lack of knowledge can lead to delayed treatment and poor health outcomes. Healthcare providers must prioritize educational initiatives to inform patients about urinary tract disorders and the role of ureteral stents in effective management, thereby addressing this critical challenge in the market.

Qatar Ureteral Stents Market Future Outlook

The future of the Qatar ureteral stents market appears promising, driven by ongoing advancements in medical technology and a growing emphasis on patient-centric healthcare solutions. As the healthcare infrastructure expands, the integration of smart technologies into stents is likely to enhance monitoring and treatment efficacy. Furthermore, the increasing demand for minimally invasive procedures will likely lead to greater adoption of innovative stent designs, ultimately improving patient outcomes and market dynamics.

Market Opportunities

  • Expansion of Healthcare Infrastructure:Qatar's government is investing heavily in healthcare infrastructure, with plans to allocate USD 20 billion in future. This investment will enhance access to advanced medical technologies, including ureteral stents, creating significant opportunities for market players to expand their reach and improve patient care.
  • Potential for Product Innovation:The demand for innovative ureteral stents is on the rise, particularly those incorporating biodegradable materials. With a projected increase in R&D spending to USD 1 billion in future, companies have the opportunity to develop cutting-edge products that meet evolving patient needs, thereby capturing a larger market share.

Scope of the Report

SegmentSub-Segments
By Type

Double-J Stents

Ureteral Catheters

Coated Stents

Biodegradable Stents

Others

By End-User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

By Material

Silicone Stents

Polyurethane Stents

Metal Stents

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Region

Doha

Al Rayyan

Umm Salal

Others

By Application

Urology

Oncology

Gynecology

Others

By Patient Demographics

Pediatric Patients

Adult Patients

Geriatric Patients

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Public Health, Qatar)

Manufacturers and Producers of Ureteral Stents

Distributors and Retailers of Medical Devices

Healthcare Providers and Hospitals

Medical Device Regulatory Authorities (e.g., Qatar's Drug Registration and Control Department)

Industry Associations and Trade Organizations

Health Insurance Companies

Players Mentioned in the Report:

Boston Scientific Corporation

Cook Medical

Medtronic

Teleflex Incorporated

B. Braun Melsungen AG

Coloplast A/S

C. R. Bard, Inc.

Olympus Corporation

Stryker Corporation

UroGen Pharma Ltd.

ConvaTec Group PLC

Merit Medical Systems, Inc.

Endo International PLC

Acelity L.P. Inc.

Amgen Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Qatar Ureteral Stents Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Qatar Ureteral Stents Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Qatar Ureteral Stents Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of urinary tract disorders
3.1.2 Advancements in medical technology
3.1.3 Rising geriatric population
3.1.4 Growing healthcare expenditure

3.2 Market Challenges

3.2.1 High cost of ureteral stents
3.2.2 Limited awareness among patients
3.2.3 Stringent regulatory requirements
3.2.4 Competition from alternative treatments

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Increasing demand for minimally invasive procedures
3.3.3 Potential for product innovation
3.3.4 Collaborations with healthcare providers

3.4 Market Trends

3.4.1 Shift towards biodegradable stents
3.4.2 Integration of smart technology in stents
3.4.3 Focus on patient-centric healthcare solutions
3.4.4 Rise in telemedicine and remote monitoring

3.5 Government Regulation

3.5.1 Regulatory approvals for new stent technologies
3.5.2 Guidelines for stent usage in clinical practice
3.5.3 Quality control standards for manufacturing
3.5.4 Policies promoting healthcare accessibility

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Qatar Ureteral Stents Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Qatar Ureteral Stents Market Segmentation

8.1 By Type

8.1.1 Double-J Stents
8.1.2 Ureteral Catheters
8.1.3 Coated Stents
8.1.4 Biodegradable Stents
8.1.5 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Ambulatory Surgical Centers
8.2.3 Specialty Clinics
8.2.4 Others

8.3 By Material

8.3.1 Silicone Stents
8.3.2 Polyurethane Stents
8.3.3 Metal Stents
8.3.4 Others

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Distributors
8.4.3 Online Sales
8.4.4 Others

8.5 By Region

8.5.1 Doha
8.5.2 Al Rayyan
8.5.3 Umm Salal
8.5.4 Others

8.6 By Application

8.6.1 Urology
8.6.2 Oncology
8.6.3 Gynecology
8.6.4 Others

8.7 By Patient Demographics

8.7.1 Pediatric Patients
8.7.2 Adult Patients
8.7.3 Geriatric Patients
8.7.4 Others

9. Qatar Ureteral Stents Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Distribution Efficiency
9.2.9 Brand Recognition
9.2.10 Customer Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Boston Scientific Corporation
9.5.2 Cook Medical
9.5.3 Medtronic
9.5.4 Teleflex Incorporated
9.5.5 B. Braun Melsungen AG
9.5.6 Coloplast A/S
9.5.7 C. R. Bard, Inc.
9.5.8 Olympus Corporation
9.5.9 Stryker Corporation
9.5.10 UroGen Pharma Ltd.
9.5.11 ConvaTec Group PLC
9.5.12 Merit Medical Systems, Inc.
9.5.13 Endo International PLC
9.5.14 Acelity L.P. Inc.
9.5.15 Amgen Inc.

10. Qatar Ureteral Stents Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Urological Devices
10.1.2 Decision-Making Process
10.1.3 Supplier Selection Criteria
10.1.4 Contracting Procedures

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Healthcare Facilities
10.2.2 Spending on Medical Equipment
10.2.3 Budget for Training and Development
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in Procurement
10.3.2 Issues with Product Availability
10.3.3 Quality Concerns
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Needs
10.4.3 Infrastructure Readiness
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Evaluation of Stent Performance
10.5.2 Cost-Benefit Analysis
10.5.3 Potential for Future Applications
10.5.4 Others

11. Qatar Ureteral Stents Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-Ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-Sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-Term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Scheduling

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of healthcare expenditure reports from the Qatar Ministry of Public Health
  • Review of medical device import/export data from Qatar's Customs Authority
  • Examination of published market reports and white papers on urology and stent technologies

Primary Research

  • Interviews with urologists and healthcare professionals specializing in urinary tract procedures
  • Surveys conducted with procurement managers at hospitals and clinics in Qatar
  • Field interviews with medical device distributors and suppliers operating in the region

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including industry reports and expert opinions
  • Triangulation of market data with clinical usage statistics and patient demographics
  • Sanity checks through expert panel discussions with key opinion leaders in urology

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare spending in Qatar allocated to urology and related procedures
  • Segmentation of market size by stent type, including ureteral, nephrostomy, and double-J stents
  • Incorporation of growth rates based on population health trends and aging demographics

Bottom-up Modeling

  • Volume estimates based on surgical procedure data and stent usage rates in hospitals
  • Cost analysis derived from pricing data of stents and associated medical services
  • Calculation of market size using unit sales multiplied by average selling prices

Forecasting & Scenario Analysis

  • Multi-variable forecasting incorporating factors such as technological advancements and regulatory changes
  • Scenario analysis based on potential shifts in healthcare policies and patient access to care
  • Development of baseline, optimistic, and pessimistic market growth projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Urology Clinics45Urologists, Clinic Managers
Hospitals with Urology Departments40Procurement Officers, Department Heads
Medical Device Distributors35Sales Managers, Product Specialists
Patient Advocacy Groups25Patient Representatives, Healthcare Advocates
Regulatory Bodies20Regulatory Affairs Managers, Compliance Officers

Frequently Asked Questions

What is the current value of the Qatar Ureteral Stents Market?

The Qatar Ureteral Stents Market is valued at approximately USD 48 million, reflecting a five-year historical analysis. This growth is driven by the increasing prevalence of urological disorders and advancements in medical technology.

Which cities dominate the Qatar Ureteral Stents Market?

What types of ureteral stents are available in Qatar?

Who are the major players in the Qatar Ureteral Stents Market?

Other Regional/Country Reports

UAE Ureteral Stents MarketKSA Ureteral Stents MarketGlobal Ureteral Stents Market

Indonesia Ureteral Stents Market

Malaysia Ureteral Stents Market

APAC Ureteral Stents Market

Other Adjacent Reports

Indonesia Urology Devices Market

Global minimally invasive surgery market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

Egypt Medical Catheters Market

Oman Biodegradable Implants Market

Mexico Endourology Instruments Market

Malaysia Kidney Stone Management Market

Bahrain Urinary Tract Devices Market

Brazil Surgical Stents Market

Qatar Interventional Urology Market

UAE Medical Implants Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022